NCT04811846View on ClinicalTrials.gov

CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 14, 2021

Primary Completion Date

May 31, 2025

Study Completion Date

October 31, 2025

Conditions
Urinary Bladder NeoplasmTransitional Cell CarcinomaUrogenital NeoplasmsCirculating Tumor CellNeoplasms
Interventions
DEVICE

Bipolar transurethral resection of bladder tumor (TURBT)

Standard resection in piecemeal technique with standard bipolar cutting loop. (Storz medical, 27040 GP1)

DEVICE

Bipolar transurethral plasma kinetic vaporization of bladder tumor (PKVBT)

Vaporization of bladder tumor with standard bipolar vaporization electrode. (Storz medical, 27040 NB)

Trial Locations (2)

5020

LKH Salzburg, Department of Urology and Andrology, Salzburg

6060

LKH Hall in Tirol, Department of Urology and Andrology, Hall in Tirol

All Listed Sponsors
collaborator

Salzburger Landeskliniken

OTHER

lead

University Teaching Hospital Hall in Tirol

OTHER